Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
7.40
+0.90 (13.85%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Armata Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Armata Pharmaceuticals stock have an average target of 17.5, with a low estimate of 15 and a high estimate of 20. The average target predicts an increase of 136.49% from the current stock price of 7.40.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 28, 2026.
Analyst Ratings
The average analyst rating for Armata Pharmaceuticals stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 2 | 2 | 2 | 2 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Reiterates $20 | Buy | Reiterates | $20 | +170.27% | May 28, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $15 | Buy | Reiterates | $15 | +102.70% | May 14, 2026 |
Financial Forecast
Revenue This Year
2.20M
from 4.90M
Decreased by -55.14%
Revenue Next Year
2.75M
from 2.20M
Increased by 25.00%
EPS This Year
-0.82
from -1.31
EPS Next Year
-0.59
from -0.82
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.6M | 5.5M | |
| Avg | 2.2M | 2.8M | |
| Low | 800,000 | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -26.6% | 150.0% | |
| Avg | -55.1% | 25.0% | |
| Low | -83.7% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.82 | -0.59 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.